LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
about
Genome-wide association studies and epigenome-wide association studies go together in cancer control.Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.Clinical and immunological correlates of long term survival in glioblastoma.Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer.Feasibility and robustness of dynamic F-FET PET based tracer kinetic models applied to patients with recurrent high-grade glioma prior to carbon ion irradiation
P2860
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
LOC283731 promoter hypermethyl ...... ld-type glioblastoma patients.
@en
type
label
LOC283731 promoter hypermethyl ...... ld-type glioblastoma patients.
@en
prefLabel
LOC283731 promoter hypermethyl ...... ld-type glioblastoma patients.
@en
P2093
P2860
P50
P356
P1476
LOC283731 promoter hypermethyl ...... ld-type glioblastoma patients.
@en
P2093
Amir Abdollahi
Andreas Unterberg
Ann-Katrin Nied
Bernd Lahrmann
Christian Hartmann
Christian Schwager
Christine Jungk
Christoph Geisenberger
Christoph Plass
Céline Dutruel
P2860
P304
P356
10.1002/IJC.30069
P50
P577
2016-03-02T00:00:00Z